Literature DB >> 15774916

Prevalence and causes of blindness and low vision in leprosy villages of north eastern Nigeria.

C Mpyet1, A W Solomon.   

Abstract

AIMS: To determine the prevalence and spectrum of ocular pathology, and the prevalence and causes of blindness and low vision in leprosy villages of north eastern Nigeria.
METHODS: People affected by leprosy, aged 30 years and above, resident in eight leprosy villages were invited to participate. Ocular examination was undertaken of each consenting individual.
RESULTS: 480 people were examined. 456 (48%) of 960 eyes had at least one ocular lesion, but only 37% of all lesions were leprosy related and potentially sight threatening. The prevalence of blindness (VA<3/60 with available correction) was 10.4%. An additional 7.5% of subjects were severely visually impaired (3/60< or =VA<6/60). Cataract was the commonest cause of blindness. Other major causes were non-trachomatous corneal opacity and trachoma.
CONCLUSIONS: Blindness and low vision are highly prevalent among leprosy patients in this setting. Only a third of the burden of ocular pathology is related to the direct effects of leprosy. Efforts to reduce the backlog of cataract and trichiasis, to improve early detection and management of lagophthalmos, and to provide refractive services are urgently required.

Entities:  

Mesh:

Year:  2005        PMID: 15774916      PMCID: PMC1772607          DOI: 10.1136/bjo.2004.048777

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  11 in total

1.  Leprosy. Global situation.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2002-01-04

2.  Cataract: the main cause of blindness in leprosy.

Authors:  M Hogeweg
Journal:  Lepr Rev       Date:  2001-06       Impact factor: 0.537

Review 3.  Leprosy at the cutting edge: 2000 to 2005, and beyond.

Authors:  C M Smith; W C S Smith
Journal:  Trop Doct       Date:  2002-01       Impact factor: 0.731

4.  Progress towards the elimination of leprosy as a public health problem.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1996-05-17

5.  Magnitude of trachoma and barriers to uptake of lid surgery in a rural community of northern Nigeria.

Authors:  M M Rabiu; A Abiose
Journal:  Ophthalmic Epidemiol       Date:  2001-07       Impact factor: 1.648

6.  Progression of eye disease in "cured" leprosy patients: implications for understanding the pathophysiology of ocular disease and for addressing eyecare needs.

Authors:  S Lewallen; N C Tungpakorn; S H Kim; P Courtright
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

7.  Ocular findings in leprosy patients in Nigeria.

Authors:  S N Nwosu; M C Nwosu
Journal:  East Afr Med J       Date:  1994-07

8.  Cataract in leprosy patients: cataract surgical coverage, barriers to acceptance of surgery, and outcome of surgery in a population based survey in Korea.

Authors:  P Courtright; S Lewallen; N Tungpakorn; B H Cho; Y K Lim; H J Lee; S H Kim
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

9.  Leprosy in a trachomatous population.

Authors:  I R Schwab; E Nassar; R Malaty; A Zarifa; A Korra; C R Dawson
Journal:  Arch Ophthalmol       Date:  1984-02

10.  Multidrug therapy and eye disease in leprosy: a cross-sectional study in the People's Republic of China.

Authors:  P Courtright; L F Hu; H Y Li; S Lewallen
Journal:  Int J Epidemiol       Date:  1994-08       Impact factor: 7.196

View more
  10 in total

1.  Ocular complications of leprosy in yemen.

Authors:  Raga A A Salem
Journal:  Sultan Qaboos Univ Med J       Date:  2012-11-20

2.  Ocular leprosy in institutionalized Nigerian patients.

Authors:  J A Ebeigbe; F Kio
Journal:  Ghana Med J       Date:  2011-06

3.  Cataract surgical coverage and barriers to uptake of cataract surgery in leprosy villages of north eastern Nigeria.

Authors:  C Mpyet; B P Dineen; A W Solomon
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

4.  Prevalence and etiologies of visual handicaps in leprosy patients in the south of Cameroon.

Authors:  André Omgbwa Eballé; Didier Owono; Alphonse Um Book; Assumpta Lucienne Bella; Come Ebana Mvogo; Nsom Mba
Journal:  Clin Ophthalmol       Date:  2009-06-02

5.  Prevalence and causes of blindness and low vision in khuzestan province, iran.

Authors:  Mostafa Feghhi; Gholamreza Khataminia; Hossein Ziaei; Mahmood Latifi
Journal:  J Ophthalmic Vis Res       Date:  2009-01

Review 6.  Epidemiology of glaucoma in sub-saharan Africa: prevalence, incidence and risk factors.

Authors:  Fatima Kyari; Mohammed M Abdull; Andrew Bastawrous; Clare E Gilbert; Hannah Faal
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Apr-Jun

7.  The Nigerian national blindness and visual impairment survey: Rationale, objectives and detailed methodology.

Authors:  Brendan Dineen; Clare E Gilbert; Mansur Rabiu; Fatima Kyari; Abdull M Mahdi; Tafida Abubakar; Christian C Ezelum; Entekume Gabriel; Elizabeth Elhassan; Adenike Abiose; Hannah Faal; Jonathan Y Jiya; Chinenyem P Ozemela; Pak Sang Lee; Murthy V S Gudlavalleti
Journal:  BMC Ophthalmol       Date:  2008-09-22       Impact factor: 2.209

8.  Outcomes of Cataract Surgery at a Referral Center.

Authors:  Seyed-Farzad Mohammadi; Hassan Hashemi; Arash Mazouri; Nazanin Rahman-A; Elham Ashrafi; Hadi Z Mehrjardi; Ramak Roohipour; Akbar Fotouhi
Journal:  J Ophthalmic Vis Res       Date:  2015 Jul-Sep

9.  Prevalence of Trachoma and Access to Water and Sanitation in Benue State, Nigeria: Results of 23 Population-Based Prevalence Surveys.

Authors:  Caleb Mpyet; Selassie Tagoh; Sophie Boisson; Rebecca Willis; Nasiru Muhammad; Ana Bakhtiari; Mohammed D Adamu; Alexandre L Pavluck; Murtala M Umar; Joel Alada; Sunday Isiyaku; William Adamani; Betty Jande; Nicholas Olobio; Anthony W Solomon
Journal:  Ophthalmic Epidemiol       Date:  2018-12       Impact factor: 1.648

10.  Prevalence of and risk factors for trachoma in Kwara state, Nigeria: Results of eight population-based surveys from the Global Trachoma Mapping Project.

Authors:  Joel J Alada; Caleb Mpyet; Victor V Florea; Sophie Boisson; Rebecca Willis; Nasiru Muhammad; Ana Bakhtiari; Mohammed D Adamu; Alexandre L Pavluck; Murtala M Umar; Sunday Isiyaku; Adamani William; Funso Olu Peter Oyinloye; Nicholas Olobio; Anthony W Solomon
Journal:  Ophthalmic Epidemiol       Date:  2018-12       Impact factor: 1.648

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.